Senti Biosciences Holdings, Inc. — Form SCHEDULE 13D/A
Filed November 18, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
New Enterprise Associates 15, L.P., NEA Partners 15, L.P., and NEA 15 GP, LLC executed an agreement on November 18, 2026 to file a single Schedule 13D disclosure regarding their combined ownership of Senti Biosciences Holdings, Inc. shares. This is a procedural filing coordinating disclosure obligations under Rule 13d-1(k)(1); no specific share count or ownership percentage is stated in this exhibit-only filing.
Why this rating
Administrative filing coordinating joint 13D disclosure. No ownership stake, acquisition, transaction, or business change disclosed. Routine regulatory compliance.
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.